patient death

pause halt pause button
Biotech

FDA freezes enrollment in MacroGenics cancer trial after death

MacroGenics had already paused enrollment in the trial of bispecific antibody lorigerlimab after four patients experienced severe side effects.
Darren Incorvaia Feb 24, 2026 2:00pm
gold arrow pointing upward forward

FDA frees Intellia of 1 clinical hold for CRISPR therapy

Jan 27, 2026 10:54am
Curtains closing on an empty stage

Pulmocide pulls ph. 3 antifungal trial over mortality rate

Jan 7, 2026 10:57am
pause halt pause button

Daiichi-Merck ph. 3 ADC program on pause after patient deaths

Dec 18, 2025 11:22am
pause button on blue background

Capsida pauses phase 1 gene therapy trial after child dies

Sep 11, 2025 7:30am
space launch rocketship

Rocket's gene therapy free from FDA hold

Aug 20, 2025 10:40am